Table 2 of Zyla, Mol Vis 2019; 25:446-461.

Table 2. Patient criteria for retrospective chart analysis.

Description # of patients
Patients taking Tecfidera™ 369
Patients that discontinued Tecfidera™ -207
Optic neuritis-naïve patients -109
Patients with unknown dates for -2
optic neuritis episodes
Patients taking Tecfidera™ analyzed in this study 51
  (39 females, 12 males)

Exclusion criteria and patient numbers used for retrospective chart analysis. An initial analysis revealed that the OMRF Multiple Sclerosis Center of Excellence had treated 369 patients with Tecfidera™ since 2013. The exclusion criteria are accompanied by a minus sign to indicate the number of patients excluded. The final analysis included 51 Tecfidera™-treated patients (39 females and 12 males).

Zyla, Mol Vis 2019; 25:446-461. http://www.molvis.org/molvis/v25/446

©2019 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535